X-Ray Powder Diffraction
Welcome to this educational resource. Here you can get an impression of what XRPD is, how it works, and where it is commonly used — from pharmaceutical development to materials characterization.
Quick Navigation
- What is XRPD? — Terminology & Fundamentals
- Major Questions Answerable with XRPD
- Methods & Applications
- XRPD for Pharmaceuticals — Polymorphism, Crystallinity, QC
- XRPD for Medical Devices & Materials — Ceramics, Coatings, Structures
- Instrumentation & Geometry
- Sample Preparation
- Understanding XRPD Data
What is XRPD — X-Ray Powder Diffraction?
What exactly is XRPD analysis? The answer "X-Ray Powder Diffraction analysis" isn't very illuminating — so let's explain it properly.
XRPD is a method for measuring the X-Rays scattered by a polycrystalline sample as a function of the scattering angle. Analysis of this distribution provides extensive information about the microstructure and properties of the sample.
What Makes a Sample "Polycrystalline"?
An XRPD sample is a "polycrystalline" sample consisting of many small, randomly oriented crystallites. This makes it different from samples used in monocrystal X-ray diffraction. Polycrystalline samples can exist in different forms:
Solid Form
Metals, ceramics, solid materials
Loose Powder
APIs, excipients, formulations
Film Form
Thin films, coatings
Suspension
Particles in liquid
Major Questions Answerable with XRPD
XRPD provides information about the microstructure of materials, which is directly linked to their physical properties. Common questions that XRPD can answer:
Material Identification
- What kind of material do I have?
- Which crystalline phases are present?
- In what amounts are they present?
- Is my sample a single phase or a mixture?
Structure Analysis
- What are the unit cell parameters?
- What is the atomic structure?
- How does the microstructure look?
- What is the crystallite size?
Process Control
- Did synthesis/processing happen correctly?
- Are there material differences within a batch?
- How does material perform in products?
IP & Regulatory
- Patent-related analysis
- Deformulation questions
- Specification compliance
What XRPD Cannot Answer
- Amorphous identification: XRPD cannot specifically identify amorphous substances (glasses, liquids) due to absence of crystalline peaks — though crystallinity quantification is an important application.
- Elemental composition: XRPD isn't always suited for identifying atomic types ("Do I have carbon?"). XRF is usually better for this — though identifying a crystalline form can often deduce composition.
Methods & Applications
Crystallography & Phase Analysis
Indexing and determination of the crystallographic unit cell. The 6 parameters (a, b, c, α, β, γ) are determined from XRPD peak positions. Databases of patterns enable identification of unknown substances.
Quantitative Phase Analysis
Determination of concentrations of different crystalline phases (or amorphous phase) in mixtures. Based on calibration curves, linear regression, or full-pattern analysis.
Rietveld Analysis
Refinement of atomic positions from a known model, based on best fit between experimental and simulated patterns. Novel methods like "Charge flipping" enable ab-initio structure determination.
Line Profile Analysis
Determination of crystallite size and micro-deformations from peak broadening. Often combined with Rietveld analysis for comprehensive characterization.
Microdiffraction
The above methods conducted with a very small X-Ray beam to obtain information about a specific spot on a sample — useful for heterogeneous materials, inclusions, or spatial mapping.
XRPD for Pharmaceuticals
XRPD is the regulatory-accepted method for controlling polymorphism in pharmaceutical products. Different polymorphs of the same drug can have dramatically different solubility, bioavailability, and stability.
Polymorph Identification
- Identify crystalline forms
- Distinguish polymorphs, hydrates, solvates
- Confirm phase purity
- Support patent applications
Polymorphic Impurity Detection
- Detection down to 0.17% wt (LOD)
- Quantification as low as 0.5% wt (LOQ)
- Critical for regulatory compliance
- Patent infringement analysis
Crystallinity Quantification
- Crystalline/amorphous ratio
- LOQ ~1% wt achievable
- Important for bioavailability
- Processing control
Unit Cell Indexing
Identification of lattice type and dimensions from peak positions. An indexed pattern uniquely fingerprints a crystalline form — critical for patent protection.
Batch Release & QC
cGMP-compliant testing for specification compliance. Identity verification, stability monitoring, and Certificate of Analysis generation.
XRPD for Medical Devices & Materials
Beyond pharmaceutical powders, XRPD is valuable for characterizing materials used in medical devices, implants, and functional coatings. Special techniques include texture analysis, stress measurements, and surface-sensitive methods.
Ceramic Materials
- Phase composition (e.g., zirconia)
- Wear track analysis
- Quality control of ceramic implants
Biocoatings
- Hydroxyapatite coating quality
- Crystallinity of bioactive layers
- Implant surface characterization
- Coating uniformity
Texture & Stress Analysis
- Crystallite orientation anisotropy
- Residual stress measurements
- Film microstructure
- Surface-sensitive methods
Advanced Surface Techniques
For solid samples with surfaces, specialized methods characterize:
- Texture analysis: Anisotropy of crystallite orientations relative to surface
- Residual stress: Microstructure relative to surface, failure prediction
- Grazing incidence: Surface-sensitive phase identification
Applications
- Orthopedic implants
- Dental ceramics
- Stent coatings
- Surgical instruments
- Wear-resistant surfaces
Instrumentation & Geometry
XRPD experiments are conducted using an X-ray powder diffractometer:
Core Components
- X-Ray source: X-Ray tube
- Generator: High voltage supply
- Sample holder: Flat plate, capillary, or well-plate
- Detector: Measures scattered X-rays
- Beam conditioners: Apertures, monochromators, mirrors
- Goniometer: Precise angular positioning
Detection Geometries
Several geometries are used for XRPD experiments:
- Bragg-Brentano (reflection): High resolution, flat sample
- Bragg-Brentano (transmission): Reduced texture effects
- Parallel beam: Tolerant of sample surface
- Debye-Scherrer: Capillary samples, minimal texture
Geometry Selection
Choice depends on sample type, required resolution, and texture sensitivity. Pharmaceutical samples typically use reflection or transmission Bragg-Brentano. Solid surfaces may require parallel beam geometry.
Sample Preparation
Ideal XRPD experiments provide clean, low-background patterns with high resolution. Sample preparation is critical — most polycrystalline substances can be altered during preparation (texture, amorphization, defects, or phase transformations).
Common Preparation Methods
- Pressed powder (reflection): Risk of texture, atmospheric exposure
- Flat layer between foils (transmission): Reduced texture effects
- Capillary (transmission): Protected sample, minimal texture, <1mg sufficient
- Thin layer deposition: allows in-depth analysis
- Loose layer: Reduced texture, unprotected
Solid Samples
Solid samples may be measured as-is or by cutting a small part:
- Flat surfaces: Bragg-Brentano geometry
- Curved/rough surfaces: Parallel beam geometry
- Coatings: Grazing incidence methods
- Specific spots: Microdiffraction
Understanding XRPD Data
When reading scientific papers or reports, you'll encounter XRPD patterns. Understanding what information can be extracted is essential.
Peak Positions
Related to crystallographic unit cell parameters. Used for phase identification and indexing.
Peak Intensities
Related to atomic arrangements within the unit cell. Used for structure refinement and quantification.
Peak Widths
Broadening indicates smaller crystallites or micro-deformations. Result of "physical" broadening, spectral width, and instrumental aberrations.
Peak Shape
May show Kα1/Kα2 doublets (without monochromator) or asymmetry from instrumental aberrations.
If you need professional XRPD testing, DANNALAB offers cGMP-compliant XRPD services for pharmaceutical development and manufacturing, including method development, validation, batch release, and stability testing.